文献速递艾滋病与性传播感染病毒性肝炎结核与非结核分枝杆菌

HIV、乙型肝炎、丙型肝炎与结核共感染的治疗复杂性

Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis.
PubMed 文献 · Lancet Infect Dis · 2021-05-21

本文通过一名有静脉吸毒史的年轻男性病例,描述其同时感染HIV、HBV、HCV并罹患播散性结核的治疗过程。先启动抗结核治疗,2个月后加用对HIV和HBV均有效的抗逆转录病毒药物,抗结核治疗9个月后以12周口服直接抗病毒药物治疗HCV成功。文章讨论了抗结核药、抗逆转录病毒药、抗HBV药及抗HCV直接抗病毒药之间的药物相互作用与治疗方案制定挑战。

要点

  • HIV/HBV/HCV与结核共感染时需兼顾疗效、药物相互作用和不良反应制定方案。
  • 该病例先抗结核、2个月后加抗逆转录病毒药,9个月抗结核后以12周DAA治愈HCV。
  • 抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA间存在多种药物相互作用需关注。

核心结论

  • HIV、HBV、HCV与结核共感染的治疗方案制定复杂,需综合管理药物相互作用与不良反应。

研究设计与样本

  • 本文为病例报告,对象为一名有静脉吸毒史的年轻男性,诊断为播散性结核并三重感染HBV、HCV和HIV。

主要发现

  • 先启动抗结核治疗,2个月后加用对HIV和HBV均有效的抗逆转录病毒药物。
  • 抗结核治疗9个月后,以12周口服直接抗病毒药物成功治疗HCV。
  • 文章描述了制定治疗方案面临的挑战及抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA之间的多种药物相互作用。

临床怎么用

  • 共感染患者应分阶段启动治疗并关注抗结核药、抗逆转录病毒药、抗HBV药与HCV DAA间的相互作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) are commonly encountered blood-borne infectious microorganisms. Infection with these viruses typically requires long-lasting drug therapy. Coinfections, especially with tuberculosis, pose a challenge to the creation of a regimen with adequate efficacy and minimal drug-drug interactions and adverse effects. We present the case of a young man with a history of intravenous drug misuse who was diagnosed with disseminated tuberculosis and with a triple infection with HBV, HCV, and HIV. The treatment for tuberculosis was initiated first, followed 2 months later by antiretrovirals that were effective against both HIV and HBV. After 9 months of antitubercular therapy, HCV was successfully treated with 12 weeks of oral direct-acting antivirals. We describe the challenges faced in formulating a therapeutic plan for such patients and discuss the various drug interactions that can arise between antitubercular drugs, antiretrovirals, anti-HBV drugs, and direct-acting antivirals against HCV.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Arora U, Garg P, Agarwal S, et al. Complexities in the treatment of coinfection with HIV, hepatitis B, hepatitis C, and tuberculosis. Lancet Infect Dis. 2021. PMID: 34023004. doi:10.1016/S1473-3099(20)30765-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。